Rick Koo

Biopharma Operations and Team Leadership Consulting

Denver Metropolitan Area

Investor

Invests in

Stages:

Seed
Pre-seed

Locations:

Colorado

  • Min Investment:

    $0.00

  • Max Investment:

    $0.00

  • Target Investment:

    $0.00

Skills

IND
Drug Development
Clinical Trials
Immunology
Oncology
Regulatory Affairs
Infectious Diseases
FDA
Clinical Development
Biotechnology
Biopharmaceuticals
Drug Discovery
Technology Transfer
Life Sciences
Pharmaceutical Industry
Cross-functional Team Leadership
Strategy
Management
Commercialization
CRO

Education

Lists including Rick

AS
AB
AR
AM

Based in Colorado

170 people

AM
AT
AS
AR

All Seed Investors

19691 people

AT
AE
AE
AL

All Pre-Seed Investors

7972 people

Work Experience

TM
Ten Mouth Corporation

2024

  • Owner

    2024

FP
First Principles Advisory Group

2016 - 2024

  • Vice President

    2016 - 2024

N
NetApp

2014 - 2015

  • Corporate and Securities Legal

    2014 - 2015

    Project-based work related to corporate development activities and securities law compliance. Diligence for strategic investments Revision of SEC periodic filing materials Creation of securities law research and training materials

Uo
University of Colorado

2013 - 2014

  • Technology Transfer Office

    2013 - 2014

    Prior art search, patentability opinions, and market assessment for life science IP generated at the Anschutz Medical Campus

G
Genentech

2001 - 2010

  • Project Team Leader

    2009 - 2010

    Genentech Research and Early Development (gRED) Associate Director, Project Team Leader - Oncology Drug Development

  • Project Team Leader - Avastin®

    2006 - 2009

    Associate Director, Project Team Leader Avastin® Breast Cancer, Gynecologic Malignancies, and Melanoma

  • Project Team Leader - Tarceva®

    2005 - 2006

    Associate Director, Project Team Leader - Tarceva®

  • Project Manager

    2001 - 2005

G
Genentech

1999 - 2000

  • Senior Operations Analyst

    1999 - 2000